Anzhelika Vorobyeva

46PUBLICATIONS
33CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Jul 31, 2026
Imaging of ROR1 expression in tumors using radiolabeled affibody molecules.

|Nov 20, 2025
Affibody-Derived Drug Conjugates Targeting The Epidermal Growth Factor Receptor Are Potent And Specific Cytotoxic Agents.

Sara S Rinne, Wen Yin, Ruonan Li

|Oct 16, 2025
Preclinical Positron Emission Tomography Imaging of B7-H3 Expression Using Affibody Molecules Labeled with Gallium-68.

Vladimir Tolmachev, Ekaterina A Bezverkhniaia, Eleftherios Papalanis

|Jun 13, 2025
Targeting of Epithelial Cell Adhesion Molecule-Expressing Malignant Tumors Using an Albumin-Binding Domain-Fused Designed Ankyrin Repeat Protein: Effect of the Molecular Architecture.

Vladimir Tolmachev, Anzhelika Vorobyeva, Alia Hani Binti Rosly

|Mar 20, 2025
Impact of Radiometal Chelates on In Vivo Visualization of Immune Checkpoint Protein Using Radiolabeled Affibody Molecules.

Vladimir Tolmachev, Eleftherios Papalanis, Ekaterina A Bezverkhniaia

|Oct 17, 2024
Affibody-Drug Conjugates Targeting the Human Epidermal Growth Factor Receptor-3 Demonstrate Therapeutic Efficacy in Mice Bearing Low Expressing Xenografts.

Jie Zhang, Sara S Rinne, Wen Yin

Pageof 8

Frequent Collaborators

40 joint publications

Anna Orlova

38 joint publications

Vladimir Tolmachev

17 joint publications

Tianqi Xu

15 joint publications

Torbjörn Gräslund